echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Acta Neurol Scand: Levetiracetam and carbamazepine can be used to treat newly diagnosed cerebral cysticercosis epilepsy

    Acta Neurol Scand: Levetiracetam and carbamazepine can be used to treat newly diagnosed cerebral cysticercosis epilepsy

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Among newly diagnosed NCC patients with medsci.


    Diagnose medsci.


    A total of 99 newly diagnosed NCC patients were included in the study and randomized for treatment.


     

    The results showed that 15 patients (15.


    In summary, the results of the study show that CBZ and LEV can be used as alternatives for newly diagnosed NCC patients, but the CBZ group has less side effects.


     

    Original source:

     

    Akhil P Santhosh, et al.


    ncbi.
    nlm.
    nih.
    gov/33006755/" target="_blank" rel="noopener">Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.